Agenus Corporate Update and First Quarter 2022 Financial Report
Botensilimab data to be presented and Phase 2 trials to launch.AGEN1571 (ILT2) clinical trials to commence and data presented at...
Botensilimab data to be presented and Phase 2 trials to launch.AGEN1571 (ILT2) clinical trials to commence and data presented at...
Clinical updates from solid tumor cancers and ARDS with allo-agenT-797 are on track for 2H 2022GMP manufacturing launch in 1H...
WARSAW, Ind., May 10, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the...
Presented Updated Clinical Data from Monotherapy Phase 1 Arm of RTX-240 Clinical Trial in Advanced Solid Tumors, Showing Clinical Responses...
SINGAPORE and BETHESDA, MD, May 10, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences, a global clinical-stage biotech company focused on discovering...
Cystic Fibrosis Foundation (CF Foundation) awarded up to $15.9 million for the ongoing ELX-02 clinical program Topline data from cystic fibrosis (CF) Phase 2 expansion treatment arms evaluating combination...
Ovid anticipates filing an investigational new drug application (IND) for OV329, a potent GABA aminotransferase inhibitor, and initiating Phase 1...
San Diego, California--(Newsfile Corp. - May 10, 2022) - Mycrodose Therapeutics showed the ability to synthesize and stabilize psilocin in...
New Federal Legislation, Financials, Innovating Technology Drives In Positive DirectionMiami, Florida--(Newsfile Corp. - May 10, 2022) - Novus Acquisition and...
Vancouver, British Columbia--(Newsfile Corp. - May 10, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing...
Toronto, Ontario--(Newsfile Corp. - May 10, 2022) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical...
Recognizing the Year's Most Significant Contributions to Canada's Innovative Healthcare IndustryToronto, Ontario--(Newsfile Corp. - May 10, 2022) - Bloom Burton...
Highlights In vitro testing of XPERIENCE™ demonstrated 4-log to 6-log reductions in planktonic (free-floating) bacteria and 4-log to 8-log reductions...
With a focus on evidence-generating medicine, Osmind brings scientific rigor to the medical community focused on advanced interventions for moderate...
WOODLAND HILLS, CA / ACCESSWIRE / May 10, 2022 / BMCS SUMCOIN INDEX FUND, INC doing business as BioTech Medics,...
STOCKHOLM, SE / ACCESSWIRE / May 10, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
FT. MYERS, FL / ACCESSWIRE / May 10, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing...
SAN FRANCISCO--(BUSINESS WIRE)--Jennifer Ernst, CEO of Tivic Health® Systems, Inc. (Nasdaq: TIVC), is an invited speaker at FORTUNE Brainstorm Health...
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and...
GARDNER, Mass., May 9, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") today announced that it has scheduled...